Par Drugs and Chemicals Limited (PAR.NS)

INR 215.15

(5.23%)

Total Liabilities Summary of Par Drugs and Chemicals Limited

  • Par Drugs and Chemicals Limited's latest annual total liabilities in 2023 was 159.79 Million INR , down -9.36% from previous year.
  • Par Drugs and Chemicals Limited's latest quarterly total liabilities in 2024 Q1 was -856.32 Million INR , down -635.9% from previous quarter.
  • Par Drugs and Chemicals Limited reported annual total liabilities of 176.29 Million INR in 2022, down -6.29% from previous year.
  • Par Drugs and Chemicals Limited reported annual total liabilities of 188.13 Million INR in 2021, down -22.16% from previous year.
  • Par Drugs and Chemicals Limited reported quarterly total liabilities of 188.94 Million INR for 2024 Q2, up 122.06% from previous quarter.
  • Par Drugs and Chemicals Limited reported quarterly total liabilities of - INR for 2023 Q1, down -100.0% from previous quarter.

Annual Total Liabilities Chart of Par Drugs and Chemicals Limited (2023 - 2015)

Historical Annual Total Liabilities of Par Drugs and Chemicals Limited (2023 - 2015)

Year Total Liabilities Total Liabilities Growth
2023 159.79 Million INR -9.36%
2022 176.29 Million INR -6.29%
2021 188.13 Million INR -22.16%
2020 241.69 Million INR 23.94%
2019 195 Million INR -12.31%
2018 222.38 Million INR -33.1%
2017 332.4 Million INR -9.77%
2016 368.38 Million INR -9.43%
2015 406.75 Million INR 0.0%

Peer Total Liabilities Comparison of Par Drugs and Chemicals Limited

Name Total Liabilities Total Liabilities Difference
Sigachi Industries Limited 2.53 Billion INR 93.687%
Ind-Swift Limited 13.45 Billion INR 98.812%
Bajaj HealthCare Limited 4.86 Billion INR 96.717%
Sakar Healthcare Limited 1.26 Billion INR 87.351%
Aurobindo Pharma Limited 152.2 Billion INR 99.895%
Innova Captab Limited 4.89 Billion INR 96.739%
Divi's Laboratories Limited 18.99 Billion INR 99.159%
AstraZeneca Pharma India Limited 3.66 Billion INR 95.635%
Morepen Laboratories Limited 4.45 Billion INR 96.417%
Mankind Pharma Limited 23.87 Billion INR 99.331%
Sequent Scientific Limited 8.27 Billion INR 98.069%
Wanbury Limited 3.15 Billion INR 94.936%
Laurus Labs Limited 42.71 Billion INR 99.626%
Nectar Lifesciences Limited 11.21 Billion INR 98.576%
Glenmark Life Sciences Limited 5.18 Billion INR 96.916%
Alembic Limited 1.43 Billion INR 88.842%
Hikal Limited 12.99 Billion INR 98.77%
Alembic Pharmaceuticals Limited 16.27 Billion INR 99.018%
Neuland Laboratories Limited 5.49 Billion INR 97.094%
J. B. Chemicals & Pharmaceuticals Limited 10.7 Billion INR 98.508%
Glenmark Pharmaceuticals Limited 65.11 Billion INR 99.755%
IOL Chemicals and Pharmaceuticals Limited 6.32 Billion INR 97.475%
Themis Medicare Limited 1.88 Billion INR 91.534%
RPG Life Sciences Limited 1.38 Billion INR 88.423%
Zydus Lifesciences Limited 71.79 Billion INR 99.777%
Lupin Limited 96.23 Billion INR 99.834%
Amrutanjan Health Care Limited 783.82 Million INR 79.614%
Wockhardt Limited 39.87 Billion INR 99.599%
Vaishali Pharma Limited 371.16 Million INR 56.949%
Aarti Pharmalabs Limited 8.25 Billion INR 98.063%
Jagsonpal Pharmaceuticals Limited 296.76 Million INR 46.155%
Jubilant Pharmova Limited 61.27 Billion INR 99.739%
FDC Limited 3.7 Billion INR 95.692%
Dr. Reddy's Laboratories Limited 106.96 Billion INR 99.851%
Kilitch Drugs (India) Limited 643.88 Million INR 75.183%
Eris Lifesciences Limited 38.26 Billion INR 99.582%
Venus Remedies Limited 1.39 Billion INR 88.527%
ZIM Laboratories Limited 2.08 Billion INR 92.321%
Bliss GVS Pharma Limited 2.1 Billion INR 92.423%
Caplin Point Laboratories Limited 3.5 Billion INR 95.442%
Shilpa Medicare Limited 12.93 Billion INR 98.764%
Albert David Limited 1.15 Billion INR 86.106%
Ajanta Pharma Limited 10.71 Billion INR 98.508%
Hester Biosciences Limited 3.59 Billion INR 95.555%
Suven Pharmaceuticals Limited 2.03 Billion INR 92.145%
Solara Active Pharma Sciences Limited 14.09 Billion INR 98.866%
Gufic Biosciences Limited 5.59 Billion INR 97.146%
Windlas Biotech Limited 1.76 Billion INR 90.935%
Procter & Gamble Health Limited 2.56 Billion INR 93.761%
Aarey Drugs & Pharmaceuticals Limited 1.72 Billion INR 90.722%
Mangalam Drugs & Organics Limited 1.97 Billion INR 91.915%
Granules India Limited 22.95 Billion INR 99.304%
Aarti Drugs Limited 11.5 Billion INR 98.611%
Bal Pharma Limited 2.51 Billion INR 93.637%
Alkem Laboratories Limited 48.6 Billion INR 99.671%
Sun Pharmaceutical Industries Limited 183.56 Billion INR 99.913%
Lincoln Pharmaceuticals Limited 1.07 Billion INR 85.129%
Medicamen Biotech Limited 940.36 Million INR 83.008%
Unichem Laboratories Limited 8.06 Billion INR 98.02%
Bafna Pharmaceuticals Limited 652.27 Million INR 75.503%
Biofil Chemicals and Pharmaceuticals Limited 288.79 Million INR 44.671%
Valiant Laboratories Limited 1.05 Billion INR 84.901%
Orchid Pharma Limited 3.84 Billion INR 95.843%
Medico Remedies Limited 438.24 Million INR 63.538%
Ind-Swift Laboratories Limited 2.28 Billion INR 93.021%
Ipca Laboratories Limited 33.74 Billion INR 99.526%
Brooks Laboratories Limited 248.6 Million INR 35.724%
Syncom Formulations (India) Limited 1.16 Billion INR 86.287%
Piramal Enterprises Limited 560.47 Billion INR 99.971%
Torrent Pharmaceuticals Limited 82.05 Billion INR 99.805%
NATCO Pharma Limited 10.53 Billion INR 98.483%
Suven Life Sciences Limited 148.62 Million INR -7.516%
Krebs Biochemicals & Industries Limited 2.97 Billion INR 94.627%
Strides Pharma Science Limited 37.68 Billion INR 99.576%
Indoco Remedies Limited 10.34 Billion INR 98.455%
Alpa Laboratories Limited 307.12 Million INR 47.971%
Lasa Supergenerics Limited 541.92 Million INR 70.514%
Sun Pharma Advanced Research Company Limited 3.89 Billion INR 95.895%